MALAT1 overexpression
|
CRC
|
MALAT1 overexpression
|
CRC
|
oxaliplatin Resistant: D – Preclinical
|
oxaliplatin Resistant: D – Preclinical
|
MALAT1 overexpression
|
HER2 Positive Breast Cancer
|
MALAT1 overexpression
|
HER2 Positive Breast Cancer
|
trastuzumab Resistant: D – Preclinical
|
trastuzumab Resistant: D – Preclinical
|
MALAT1 overexpression
|
Osteosarcoma
|
MALAT1 overexpression
|
Osteosarcoma
|
doxorubicin hydrochloride Resistant: D – Preclinical
|
doxorubicin hydrochloride Resistant: D – Preclinical
|
MALAT1 overexpression
|
NSCLC
|
MALAT1 overexpression
|
NSCLC
|
gemcitabine Resistant: D – Preclinical
|
gemcitabine Resistant: D – Preclinical
|